206 related articles for article (PubMed ID: 23555717)
1. Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China.
Qu L; Kuai X; Liu T; Chen T; Ni Z; Shen X
PLoS One; 2013; 8(3):e59583. PubMed ID: 23555717
[TBL] [Abstract][Full Text] [Related]
2. Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China.
Qu LS; Liu TT; Jin F; Guo YM; Chen TY; Ni ZP; Shen XZ
Hepatol Res; 2011 Jan; 41(1):54-63. PubMed ID: 20973883
[TBL] [Abstract][Full Text] [Related]
3. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.
Qu LS; Liu JX; Liu TT; Shen XZ; Chen TY; Ni ZP; Lu CH
PLoS One; 2014; 9(5):e98257. PubMed ID: 24849936
[TBL] [Abstract][Full Text] [Related]
4. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
[TBL] [Abstract][Full Text] [Related]
5. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
6. Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.
Chu CM; Lin CC; Lin SM; Lin DY; Liaw YF
Dig Dis Sci; 2012 Jan; 57(1):232-8. PubMed ID: 21837473
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
[TBL] [Abstract][Full Text] [Related]
8. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.
Tong MJ; Blatt LM; Kao JH; Cheng JT; Corey WG
Liver Int; 2007 Dec; 27(10):1356-63. PubMed ID: 17900245
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
[TBL] [Abstract][Full Text] [Related]
10. Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China.
Qu LS; Zhu J; Liu TT; Shen XZ; Chen TY; Ni ZP; Ni RZ; Lu CH
Hepatol Res; 2014 Nov; 44(12):1186-95. PubMed ID: 24341484
[TBL] [Abstract][Full Text] [Related]
11. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.
Fang ZL; Sabin CA; Dong BQ; Wei SC; Chen QY; Fang KX; Yang JY; Huang J; Wang XY; Harrison TJ
J Gen Virol; 2008 Nov; 89(Pt 11):2882-2890. PubMed ID: 18931087
[TBL] [Abstract][Full Text] [Related]
13. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
[TBL] [Abstract][Full Text] [Related]
14. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
Chen BF
World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
[TBL] [Abstract][Full Text] [Related]
15. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma.
Bai X; Zhu Y; Jin Y; Guo X; Qian G; Chen T; Zhang J; Wang J; Groopman JD; Gu J; Tu H
Carcinogenesis; 2011 Jan; 32(1):63-8. PubMed ID: 20876702
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.
Su CW; Chiou YW; Tsai YH; Teng RD; Chau GY; Lei HJ; Hung HH; Huo TI; Wu JC
PLoS One; 2013; 8(6):e66457. PubMed ID: 23805222
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
[TBL] [Abstract][Full Text] [Related]
18. Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
Li GJ; Harrison TJ; Yang JY; Chen QY; Wang XY; Fang ZL
Liver Int; 2013 Jul; 33(6):936-43. PubMed ID: 23517325
[TBL] [Abstract][Full Text] [Related]
19. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.
Tanaka Y; Mukaide M; Orito E; Yuen MF; Ito K; Kurbanov F; Sugauchi F; Asahina Y; Izumi N; Kato M; Lai CL; Ueda R; Mizokami M
J Hepatol; 2006 Nov; 45(5):646-53. PubMed ID: 16935384
[TBL] [Abstract][Full Text] [Related]
20. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
